Fennec Pharmaceuticals Inc.
FENCFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Fennec Pharmaceuticals Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 28 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 10, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Fennec Pharmaceuticals Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-05-16 · Raykov Rosty: Larger than 33 of the 36 other insider sales of Common shares on file. SEC filing
- 2024-04-22 · Haigh Adrian: Larger than all 15 other insider sales of Common Shares on file. SEC filing
- 2024-04-05 · Raykov Rosty: Larger than all 36 other insider sales of Common shares on file. SEC filing
- 2024-04-04 · Raykov Rosty: Larger than 35 of the 36 other insider sales of Common shares on file. SEC filing
- 2024-04-03 · Raykov Rosty: Larger than 34 of the 36 other insider sales of Common shares on file. SEC filing
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-01 | Raykov Rosty · Director | Common shares | S — Open market or private sale | −9,747 | 9.62 | SEC filing |
| 2026-05-11 | RALLIS CHRIS A · Director | Common Shares | S — Open market or private sale | −8,346 | 7.04 | SEC filing |
| 2026-05-01 | Raykov Rosty · Director | Common shares | S — Open market or private sale | −10,781 | 6.47 | SEC filing |
| 2026-04-01 | Raykov Rosty · Director | Common shares | S — Open market or private sale | −10,946 | 6.31 | SEC filing |
| 2026-03-02 | Raykov Rosty · Director | Common shares | S — Open market or private sale | −10,079 | 8.36 | SEC filing |
| 2026-02-02 | Raykov Rosty · Director | Common shares | S — Open market or private sale | −10,349 | 7.76 | SEC filing |
| 2026-01-02 | Raykov Rosty · Director | Common shares | S — Open market or private sale | −10,312 | 7.60 | SEC filing |
| 2025-12-24 | Southpoint Capital Advisors LP · 10% owner | Common Stock | S — Open market or private sale | −1,000,000 | 7.50 | SEC filing |
Showing 8 of 14 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-10 | Islam Khalid · Director | Stock Option | A — Grant, award, or other acquisition | +25,000 | SEC filing |
| 2026-06-10 | Cook Jodi A · Director | Stock Options | A — Grant, award, or other acquisition | +20,000 | SEC filing |
| 2026-06-10 | RALLIS CHRIS A · Director | Stock Option | A — Grant, award, or other acquisition | +20,000 | SEC filing |
| 2026-06-10 | Brughera Marco Maria · Director | Stock Option | A — Grant, award, or other acquisition | +20,000 | SEC filing |
| 2026-06-01 | Raykov Rosty · Director | Stock Options | M — Exercise or conversion of derivative security | −15,597 | SEC filing |
| 2026-06-01 | Raykov Rosty · Director | Common shares | M — Exercise or conversion of derivative security | +15,597 | SEC filing |
| 2026-05-31 | Raykov Rosty · Director | Common shares | A — Grant, award, or other acquisition | +2,778 | SEC filing |
| 2026-05-31 | Hackman Jeffrey S. · Chief Executive Officer | Common Shares | A — Grant, award, or other acquisition | +1,159 | SEC filing |
Showing 8 of 24 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.